These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3884503)

  • 1. Does renin determine the blood pressure response to calcium entry blockers?
    Waeber B; Nussberger J; Brunner HR
    Hypertension; 1985; 7(2):223-7. PubMed ID: 3884503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-adrenoceptor blockade in renal hypertensive rats with low and high renin levels.
    Waeber B; Nussberger J; Brunner HR
    Am J Physiol; 1984 Apr; 246(4 Pt 2):H573-8. PubMed ID: 6326598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.
    Leonetti G; Cuspidi C; Sampieri L; Terzoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S319-24. PubMed ID: 6184561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of two-kidney one clip renovascular hypertension in the rat.
    Thurston H; Bing RF; Swales JD
    Hypertension; 1980; 2(3):256-65. PubMed ID: 6993357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive rats.
    Waeber B; Gavras H; Gavras I; Chao P; Kohlman O; Bresnahan MR; Brunner HR; Vaughan D
    J Pharmacol Exp Ther; 1982 Nov; 223(2):510-5. PubMed ID: 6752375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the hypotensive effects of calcium antagonists.
    Erne P; Bolli P; Bertel O; Hulthen UL; Kiowski W; Muller FB; Buhler F
    Hypertension; 1983; 5(4 Pt 2):II97-102. PubMed ID: 6345378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists.
    Muiesan G; Agabiti-Rosei E; Romanelli G; Muiesan ML; Castellano M; Beschi M
    Am J Cardiol; 1986 Feb; 57(7):44D-49D. PubMed ID: 3006466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of atrial natriuretic peptide in the diuretic effect of Ca2+ entry blockers.
    Shamiss A; Peleg E; Rosenthal T; Ezra D
    Eur J Pharmacol; 1993 Mar; 233(1):113-7. PubMed ID: 8472740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition.
    Bauer JH; Sunderrajan S; Reams G
    Am J Cardiol; 1985 Dec; 56(16):62H-67H. PubMed ID: 2933950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of renal nerves in rats with low-sodium, one-kidney hypertension.
    Vari RC; Freeman RH; Davis JO; Sweet WD
    Am J Physiol; 1986 Feb; 250(2 Pt 2):H189-94. PubMed ID: 3511734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intrarenal infusion of calcium entry blockers in anesthetized dogs.
    Dietz JR; Davis JO; Freeman RH; Villarreal D; Echtenkamp SF
    Hypertension; 1983; 5(4):482-8. PubMed ID: 6345359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressure control of renal renin release in Lyon hypertensive rats.
    Medeiros IA; Zhang BL; Bertolino S; Sassard J
    J Hypertens; 1994 Aug; 12(8):871-7. PubMed ID: 7529276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SC-56525, a potent, orally active renin inhibitor, in salt-depleted and renal hypertensive dogs.
    McMahon EG; Yang PC; Babler MA; Bittner SE; Suleymanov OD; Cain-Janicki KJ; Bedell LJ; Hanson GJ; Cook CS
    Hypertension; 1995 Jul; 26(1):95-100. PubMed ID: 7607739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of atrial natriuretic factor on blood pressure, renin, and aldosterone in Goldblatt hypertension.
    Volpe M; Odell G; Kleinert HD; Müller F; Camargo MJ; Laragh JH; Maack T; Vaughan ED; Atlas SA
    Hypertension; 1985; 7(3 Pt 2):I43-8. PubMed ID: 3158607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium blockade in arterial hypertension. Review.
    Lederballe Pedersen O
    Hypertension; 1983; 5(4 Pt 2):II74-9. PubMed ID: 6222972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma renin and sodium balance during development of moderate and severe renal hypertension in rats.
    Leenen FH; de Jong W
    Circ Res; 1975 Jun; 36(6 Suppl 1):179-86. PubMed ID: 1132077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities and differences in the antihypertensive effect of two calcium antagonist drugs, verapamil and nifedipine.
    Agabiti-Rosei E; Muiesan ML; Romanelli G; Castellano M; Beschi M; Corea L; Muiesan G
    J Am Coll Cardiol; 1986 Apr; 7(4):916-24. PubMed ID: 3514729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of DOCA-salt on angiotensin dependency and surgical reversal of hypertension in two-kidney, one clip renal hypertensive rats.
    Takata Y; Doyle AE
    J Hypertens; 1983 Jun; 1(1):57-63. PubMed ID: 6397514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ; Boyd GW; Peart WS
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.